Stanford review links metformin use to lower post-COVID death risk
A Stanford-led analysis of U.S. medical records found adults with type 2 diabetes who took metformin before testing positive for COVID-19 had a 39% lower risk of dying within a year than those on DPP-4 inhibitors.
This is HUB News’s original summary. Read the complete report at Fox News.